WallStreetZenWallStreetZen

NASDAQ: TLSA
Tiziana Life Sciences Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TLSA stock forecasts and price targets.

Forecast return on equity

Is TLSA forecast to generate an efficient return?

Company
-577.7%
Industry
18.17%
Market
346.62%
TLSA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TLSA forecast to generate an efficient return on assets?

Company
-201.51%
Industry
12.38%
TLSA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TLSA earnings per share forecast

What is TLSA's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.20

TLSA revenue forecast

What is TLSA's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0

TLSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TLSA$1.38N/AN/A
IPHA$1.78$5.00+180.90%Buy
CRBU$1.62$10.00+517.28%Strong Buy
IPSC$1.79$3.00+67.60%Buy
IRD$2.29$8.00+249.34%Strong Buy
View Top Biotech Stocks

Tiziana Life Sciences Stock Forecast FAQ

What is TLSA's earnings growth forecast for 2026-2026?

(NASDAQ: TLSA) Tiziana Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Tiziana Life Sciences's earnings in 2026 is -$11,863,000.

In 2026, TLSA is forecast to generate -$22,738,374 in earnings, with the lowest earnings forecast at -$21,846,673 and the highest earnings forecast at -$23,407,150.

If you're new to stock investing, here's how to buy Tiziana Life Sciences stock.

What is TLSA's revenue growth forecast for 2026-2026?

(NASDAQ: TLSA) Tiziana Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Tiziana Life Sciences's revenue in 2026 is $0.

In 2026, TLSA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is TLSA's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: TLSA) forecast ROA is -201.51%, which is lower than the forecast US Biotechnology industry average of 12.38%.

What is TLSA's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: TLSA) Tiziana Life Sciences's current Earnings Per Share (EPS) is -$0.11. In 2026, TLSA's EPS is forecast to hit -$0.20 (min: -$0.20, max: -$0.21).

What is TLSA's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: TLSA) forecast ROE is -577.7%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.